Supply and Support of REBOA

Concepts

• bristol
• balloon catheters
• prytime medical devices inc
• leidos supply ltd
• main reboa devices
• support of reboa
• support of resuscitative endovascular balloon occlusion of the aorta
• reboa
• prior publication of a contract notice
• antihaemorrhagics

Location

United Kingdom:

Description

Leidos Supply Ltd intends to award a framework agreement to Prytime Medical Devices Inc for the supply and support of Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA). This agreement will last for up to 3 years. Please note, this is NOT a request for companies to express interest.

Total Quantity or Scope

This agreement will last for up to 3 years with an estimated value of £272,000 - £680,000. It is considered that this contract can be placed using the negotiated procedure without prior publication of a contract notice pursuant to Article 32 (b)(ii) of Directive 2014/24/EC of the European parliament and of the council (regulation 32(2) (ii) of PCR 2015). Under regulation 32 (2)(b)(ii) of the Public Contract Regulations 2015 using the negotiated procedure without prior publication when competition is absent for technical reasons. Prytime Medical Devices Inc are the sole vendor to the UK for the main REBOA devices (catheter and catheter kit) required by the Ministry of Defence customer. If a company was selected that is not manufacturer approved then this could alter the performance characteristics of the devices, as well as potentially incurring significant medical malpractice claims.

Award Detail

Award Criteria

CPV Codes

• 33141210 - Balloon catheters
• 33621200 - Antihaemorrhagics

Legal Justification

Please explain in a clear and comprehensive manner why the award of the contract without prior publication in the Official Journal of the European Union is lawful, by stating the relevant facts and, as appropriate, the conclusions of law in accordance with the directive: (500 words maximum) Leidos Supply Ltd intends to award a framework agreement to Prytime Medical Devices Inc for the supply and support of Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA). This agreement will last for up to 3 years with an estimated value of £272,000 - £680,000. It is considered that this contract can be placed using the negotiated procedure without prior publication of a contract notice pursuant to Article 32 (b)(ii) of Directive 2014/24/EC of the European parliament and of the council (regulation 32(2) (ii) of PCR 2015). Under regulation 32 (2)(b)(ii) of the Public Contract Regulations 2015 using the negotiated procedure without prior publication when competition is absent for technical reasons. Prytime Medical Devices Inc are the sole vendor to the UK for the main REBOA devices (catheter and catheter kit) required by the Ministry of Defence customer. If a company was selected that is not manufacturer approved then this could alter the performance characteristics of the devices, as well as potentially incurring significant medical malpractice claims.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **